Pune, Maharastra -- (SBWire) -- 11/23/2015 --There are several low-cost and portable cell monitoring devices in the pipeline. Currently there are some portable automated CD4+ T-cell counters in the market such as PointCare NOW (Paratec, Pima Test (Alere), Daktari CD4+ (Daktari). These devices use 25 microliters of blood and provide the results on the same day. The PointCare NOW and CyFlow mini POC measures the absolute CD4+ T-cell count.
According to the Global Cell Counting Market 2015-2019 report, development of highly sensitive POCT and automation of cell counting equipment will drive the growth of the global cell monitoring market. The POC diagnostic tests are mostly favored by hospitals and clinics and are affordable for the patients. The manufacturers are developing portable POC equipment for cell counting.
This market is estimated to grow at a steady rate during the forecast period and is positively influenced by factors like the growing establishment of diagnostic centers in rural areas. Additionally, the ability of these devices to provide rapid test results is a significant factor that results in its steady CAGR of more than 7% by 2019.
The market research analyst has estimated the Americas to account for more than 41% of the total market share by 2019. The increasing adoption of automated analyzers by laboratories in the North American region is a critical factor that drives market growth in the Americas during the forecast period.
Application-based segmentation of the cell counting market: Mass spectrometry, Cell imaging, Flow cytometry and Hemato analyzer.
Mass spectrometry is used to understand the molecular mass and structural information of cells. This segment currently dominates the global market for cell counting devices and factors like increased speed, higher accuracy, and high portability of these devices are expected to foster market growth during the next four years.
Order a Copy of Report at http://www.rnrmarketresearch.com/global-cell-counting-market-2015-2019-market-report.html
Product-based segmentation of the cell counting market: Equipment and Reagents
The market research analysts estimate the reagents segment to account for 80% of the total sales by 2019. Since most diagnostic centers rent equipment and purchase reagents, the sale of reagents is expected to increase steadily during the next four years. The usability of these reagents across a variety of tests is a key factor that drives sales during the forecast period.
The following companies are the key players in the Global Cell Counting Market: BD, Bio-Rad, EMD Millipore and Thermo Fisher Scientific
Other Prominent Vendors in the market are: AccuBioTech, Agappe Diagnostics, Analyticon, Beckman Coulter, ChemoMetec, EKF Diagnostic, ERBA Mannheim, HomeCue, Horiba Scientific, Human Diagnostics, Logos Biosystem, Mindray, Melet Schloesing Laboratories, Nihon Kohden, Olympus LifeScience Solution, Rayto, SFRI, and Sysmex Corporation.
Further, the report states that the cell counting equipment is highly technical, containing a complex system made of many parts such as electrodes, highly senstive sensors, and a monitor. A high degree of technical expertise is required to effectively use this equipment to record data and diagnose the diseases. There is a risk of false recordings due to artifacts arising from other sites.
Single User License Copy is for US $2500, get DISCOUNT at
http://www.rnrmarketresearch.com/contacts/discount?rname=430642
About RnRMarketResearch.com
RnRMarketResearch.com is your single source for all market research needs. Our database includes 100,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
Cell Counting Market to See Steady CAGR Growth of More Than 7% by 2019